RS Go et al.: Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare ... The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: ... RA Kyle et al.: Monoclonal gammopathy of undetermined significance. In: Br J Hematol. 134. Jahrgang, Nr. 6, September 2006, S. ... JA Katzmann et al.: Screening Panels for Detection of Monoclonal Gammopathies. In: Clin Chem. 55. Jahrgang, Nr. 8, 2009, S. ...

Kyle et al.: Prevalence of monoclonal gammopathy of undetermined significance. In: N Engl J Med. 354. Jahrgang, Nr. 13, 2006, S ... N van de Donk et al.: The clinical relevance and management of monoclonal gammopathy of undetermined significance and related ... T Golombick et al.: Prevalence of monoclonal gammopathy of undetermined significance/myeloma in patients with acute ... N Steiner et al.: Are neurological complications of monoclonal gammopathy of undetermined significance underestimated? In: ...

R. S. Go et al.: Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare ... N. van de Donk et al.: The clinical relevance and management of monoclonal gammopathy of undetermined significance and related ... T Golombick et al.: Prevalence of monoclonal gammopathy of undetermined significance/myeloma in patients with acute ... N Steiner et al.: Are neurological complications of monoclonal gammopathy of undetermined significance underestimated? In: ...

A Dispenzieri et al.: Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a ... N van de Donk et al.: The clinical relevance and management of monoclonal gammopathy of undetermined significance and related ... N Leung et al.: Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. In: Blood. ... F Bridoux et al.: Diagnosis of monoclonal gammopathy of renal significance. In: Kidney Int. 87. Jahrgang, Nr. 4, 28. Februar ...

A Dispenzieri et al.: Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a ... RA Kyle et al.: A long-term study of prognosis in monoclonal gammopathy of undetermined significance. In: N Engl J Med. 346. ... RA Kyle et al.: Prevalence of monoclonal gammopathy of undetermined significance. In: N Engl J Med. 354. Jahrgang, Nr. 13, 30. ... N van de Donk et al.: The clinical relevance and management of monoclonal gammopathy of undetermined significance and related ...

N van de Donk et al.: The clinical relevance and management of monoclonal gammopathy of undetermined significance and related ... RA Kyle et al.: Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma:IMWG ... free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. In ... and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. In: Clin Chem. 57. ...

Effects Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective ... R. A. Kyle et al.: Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: ... free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. In ... M. A. Alyanakian et al.: Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies ...

V. Rajkumar, A. Dispenzieri, R. Kyle: Monoclonal gammopathy of undetermined significance, waldenstrom macroglobulinemia, AL ... Jean A. Bernard, 98, Dies; Found Cancer in Shah of Iran. In: New York Times. 30. April 2006. Abgerufen 16. April 2015. (Non- ... In: American Society of Hematogy. Washington, DC 1999. ...